Dynavax Technologies Stock (NASDAQ: DVAX) stock price, news, charts, stock research, profile.
Open | $11.000 |
Close | - |
Volume / Avg. | 1.567M / 1.981M |
Day Range | 10.480 - 11.160 |
52 Wk Range | 10.570 - 15.150 |
Market Cap | $1.438B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 32 |
Short Interest | 17.31% |
Days to Cover | 12.29 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Dynavax Technologies (NASDAQ: DVAX) through any online brokerage.
Other companies in Dynavax Technologies’s space includes: Gyre Therapeutics (NASDAQ:GYRE), 4D Molecular Therapeutics (NASDAQ:FDMT), Syndax Pharmaceuticals (NASDAQ:SNDX), Prothena Corp (NASDAQ:PRTA) and Fusion Pharmaceuticals (NASDAQ:FUSN).
The latest price target for Dynavax Technologies (NASDAQ: DVAX) was reported by HC Wainwright & Co. on Thursday, May 9, 2024. The analyst firm set a price target for 29.00 expecting DVAX to rise to within 12 months (a possible 164.00% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Dynavax Technologies (NASDAQ: DVAX) is $10.985 last updated Today at May 9, 2024 at 11:47 AM EDT.
There are no upcoming dividends for Dynavax Technologies.
Dynavax Technologies’s Q2 earnings are confirmed for Thursday, August 1, 2024.
There is no upcoming split for Dynavax Technologies.
Dynavax Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.